These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 12928128)

  • 1. [Mode of action of botulinum neurotoxin: pathological, cellular and molecular aspect].
    Poulain B; Humeau Y
    Ann Readapt Med Phys; 2003 Jul; 46(6):265-75. PubMed ID: 12928128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanisms of action of botulinum toxins and neurotoxins].
    Poulain B; Lonchamp E; Jover E; Popoff MR; Molgó J
    Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S73-6. PubMed ID: 19576489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clostridium botulinum and botulinum neurotoxin].
    Hirai Y
    Brain Nerve; 2011 Jul; 63(7):755-61. PubMed ID: 21747146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of synaptic neurotransmitter release mechanisms using bacterial toxins].
    Doussau F; Humeau Y; Vitiello F; Popoff MR; Poulain B
    J Soc Biol; 1999; 193(6):457-67. PubMed ID: 10783704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How botulinum and tetanus neurotoxins block neurotransmitter release.
    Humeau Y; Doussau F; Grant NJ; Poulain B
    Biochimie; 2000 May; 82(5):427-46. PubMed ID: 10865130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Action mechanisms of botulinum neurotoxins and tetanus neurotoxins].
    Deloye F; Doussau F; Poulain B
    C R Seances Soc Biol Fil; 1997; 191(3):433-50. PubMed ID: 9295967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetanus and botulinum neurotoxins: mechanism of action and therapeutic uses.
    Pellizzari R; Rossetto O; Schiavo G; Montecucco C
    Philos Trans R Soc Lond B Biol Sci; 1999 Feb; 354(1381):259-68. PubMed ID: 10212474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular mechanism of action of tetanus toxin and botulinum neurotoxins].
    Poulain B
    Pathol Biol (Paris); 1994 Feb; 42(2):173-82. PubMed ID: 7916455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetanus and botulinum neurotoxins: turning bad guys into good by research.
    Rossetto O; Seveso M; Caccin P; Schiavo G; Montecucco C
    Toxicon; 2001 Jan; 39(1):27-41. PubMed ID: 10936621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mechanism of action and therapeutic uses of botulinum and tetanus neurotoxins].
    Popoff MR; Marvaud JC; Raffestin S
    Ann Pharm Fr; 2001 May; 59(3):176-90. PubMed ID: 11427819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presynaptic protein interactions in vivo: evidence from botulinum A, C, D and E action at frog neuromuscular junction.
    Raciborska DA; Trimble WS; Charlton MP
    Eur J Neurosci; 1998 Aug; 10(8):2617-28. PubMed ID: 9767392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of the endopeptidase activity of purified botulinum neurotoxins A and E by an isolated component of the native neurotoxin associated proteins.
    Sharma SK; Singh BR
    Biochemistry; 2004 Apr; 43(16):4791-8. PubMed ID: 15096048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25.
    Blasi J; Chapman ER; Link E; Binz T; Yamasaki S; De Camilli P; Südhof TC; Niemann H; Jahn R
    Nature; 1993 Sep; 365(6442):160-3. PubMed ID: 8103915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The C-terminal heavy-chain domain of botulinum neurotoxin a is not the only site that binds neurons, as the N-terminal heavy-chain domain also plays a very active role in toxin-cell binding and interactions.
    Ayyar BV; Aoki KR; Atassi MZ
    Infect Immun; 2015 Apr; 83(4):1465-76. PubMed ID: 25624352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clostridium botulinum neurotoxins act with a wide range of potencies on SH-SY5Y human neuroblastoma cells.
    Purkiss JR; Friis LM; Doward S; Quinn CP
    Neurotoxicology; 2001 Aug; 22(4):447-53. PubMed ID: 11577803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells.
    Dong M; Richards DA; Goodnough MC; Tepp WH; Johnson EA; Chapman ER
    J Cell Biol; 2003 Sep; 162(7):1293-303. PubMed ID: 14504267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-Vivo Neutralization of Botulinum Neurotoxin Serotype E Using Rabbit Polyclonal Antibody Developed against BoNT/E Light Chain.
    Rani S; Ponmariappan S; Sharma A; Kamboj DV; Jain AK
    Protein Pept Lett; 2017; 24(6):495-502. PubMed ID: 28260503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synaptic transmission: inhibition of neurotransmitter release by botulinum toxins.
    Dolly O
    Headache; 2003; 43 Suppl 1():S16-24. PubMed ID: 12887390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double receptor anchorage of botulinum neurotoxins accounts for their exquisite neurospecificity.
    Rummel A
    Curr Top Microbiol Immunol; 2013; 364():61-90. PubMed ID: 23239349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clostridium botulinum toxins: a general review of involvement in disease, structure, mode of action and preparation for clinical use.
    Hambleton P
    J Neurol; 1992 Jan; 239(1):16-20. PubMed ID: 1311751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.